Becton Dickinson (BDX) announced application of CE Mark for the Liverty TIPS Stent Graft in the European Union.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BDX:
- 3 Best Dividend Aristocrat Stocks to Buy Now, 04/02/2026
- Becton Dickinson launches ai-enabled medication dispensing system in Europe
- Becton Dickinson price target lowered to $180 from $230 at Argus
- The Week That Was, The Week Ahead: Macro and Markets, Mar. 8
- Becton Dickinson receives FDA clearance for Surgiphor 1000mL